TG Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 26, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	5,535	4,320	2,416	1,584	2,488	6,703	Upgrade
Market Cap Growth	160.03%	78.80%	52.51%	-36.33%	-62.88%	515.51%	Upgrade
Enterprise Value	5,513	4,233	2,297	1,491	2,159	6,490	Upgrade
Last Close Price	37.95	30.10	17.08	11.83	19.00	52.02	Upgrade
PE Ratio	159.36	184.75	190.66	-	-	-	Upgrade
Forward PE	32.67	45.21	-	-	-	-	Upgrade
PS Ratio	14.28	13.13	10.34	568.84	371.96	44096.70	Upgrade
PB Ratio	23.23	19.43	15.05	27.04	10.49	12.91	Upgrade
P/TBV Ratio	23.32	19.43	15.05	27.41	10.53	12.93	Upgrade
EV/Sales Ratio	14.27	12.87	9.83	535.24	322.82	42698.06	Upgrade
EV/EBITDA Ratio	92.08	100.79	110.20	-	-	-	Upgrade
EV/EBIT Ratio	92.16	100.95	111.33	-	-	-	Upgrade
Debt / Equity Ratio	1.07	1.14	0.69	1.42	0.34	0.08	Upgrade
Debt / EBITDA Ratio	4.10	5.74	4.82	-	-	-	Upgrade
Asset Turnover	0.75	0.73	0.89	0.01	0.01	0	Upgrade
Inventory Turnover	0.41	0.51	-	-	-	-	Upgrade
Quick Ratio	2.91	4.85	5.00	3.04	4.84	6.92	Upgrade
Current Ratio	4.02	6.25	5.92	3.16	5.06	6.99	Upgrade
Return on Equity (ROE)	19.70%	12.21%	11.57%	-151.36%	-92.03%	-100.14%	Upgrade
Return on Assets (ROA)	7.26%	5.78%	4.93%	-47.61%	-42.87%	-43.36%	Upgrade
Return on Capital (ROIC)	9.79%	7.00%	6.24%	-59.52%	-49.04%	-53.28%	Upgrade
Return on Capital Employed (ROCE)	12.00%	8.60%	7.50%	-	-	-	Upgrade
Earnings Yield	0.71%	0.54%	0.52%	-14.13%	-13.99%	-4.17%	Upgrade
FCF Yield	-1.10%	-0.94%	-1.30%	-11.12%	-11.90%	-3.21%	Upgrade
Buyback Yield / Dilution	-9.66%	-7.96%	-9.67%	-2.41%	-14.64%	-30.51%	Upgrade

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q